Sign In

Credits Offered

  • Continuing Medical Education (CME): 11.00 AMA PRA Category 1 Credits

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Monday, October 15, 2018. A link to the CME evaluation will be emailed to attendees after the meeting.

Trainee Travel Award

A limited number of travel awards in the amount of $500 (per award) will be available for trainees in the field of hepatology with a special interest in the conference topic. In order to qualify for a travel award, an abstract on related research must be submitted and accepted.

Learning Objectives

Upon completion of this activity, learners will be able to:

  • Understand basic concepts underlying tissue fibrosis.
  • Grasp new principles surrounding the biology of the microbiome in the pathogenesis of fibrosis.
  • Gain insights into how basic science discoveries may be translated to new therapeutics.

Target Audience

  • Pharmacists
  • Fellows/Trainees
  • Other health care professionals
    Specify: Scientists, graduate, post graduate students, FDA staff, Biomedical Industry

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: Patient-centered Care, Work in Interdisciplinary Teams, Evidence-based Practice, Quality Improvement Utilize Informatics, Medical Knowledge, Teams and Teamwork and Translating Data From the Bench to Medical Therapy.